SlideShare a Scribd company logo
Synthetic Biology:   From Bugs to Drugs and Fuels Jay D. Keasling Joint BioEnergy Institute Lawrence Berkeley National Laboratory University of California, Berkeley
Building a computer from off-the-shelf parts System Off-the-shelf components Idea Knowledge Base
Building a computer from off-the-shelf parts System Off-the-shelf components Idea Knowledge Base
Building a computer from off-the-shelf parts System Off-the-shelf components Idea Knowledge Base
Building a computer from off-the-shelf parts System Off-the-shelf components Idea Knowledge Base
Building a computer from off-the-shelf parts System Off-the-shelf components Idea Knowledge Base
Building a computer from off-the-shelf parts System Off-the-shelf components Knowledge Base Characterization Idea
Building a computer from off-the-shelf parts System Off-the-shelf components Knowledge Base Characterization Standard  Connections Idea
Building a computer from off-the-shelf parts System Off-the-shelf components Knowledge Base Characterization Standard  Connections Independent Devices Idea
Building a computer from off-the-shelf parts System Off-the-shelf components Knowledge Base Characterization Standard  Connections Independent Devices Models, Design, & Debugging Idea
Building a computer from off-the-shelf parts System Off-the-shelf components Knowledge Base Characterization Standard  Connections Independent Devices Models, Design, & Debugging Silicon Wafer Processing Idea
Styrene
Synthesis of Styrene System Off-the-shelf components Idea Knowledge Base
Synthesis of Styrene System Off-the-shelf components Idea Knowledge Base
Synthesis of Styrene System Off-the-shelf components Idea Knowledge Base
Synthesis of Styrene System Off-the-shelf components Idea Knowledge Base Chemistry
Synthesis of Styrene System Off-the-shelf components Idea Knowledge Base Chemistry Kinetics & Reactor Design
Synthesis of Styrene System Off-the-shelf components Knowledge Base Chemistry Kinetics & Reactor Design Mass Transfer Process Design Standard Connections Idea
Some common features ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Microbial synthesis of artemisinin System Off-the-shelf components Knowledge Base Idea
Malaria ,[object Object],[object Object],[object Object],[object Object],Source: Roll Back Malaria World Malaria Report 2005
[object Object],Quinine-based drugs ,[object Object],Source: Roll Back Malaria World Malaria Report 2005
Artemisinin Artemisia annua
A brief history of artemisinin 168 B.C. Recipes For 52 Kinds Of Diseases  found in the Mawangdui Han Dynasty tomb  Hemorrhoids 340 A.D. Zhou Hou Bei Ji Fang (Handbook of Prescriptions for Emergency Treatments)    Fevers (malaria) 1972 Active ingredient (artemisinin) isolated
Artemisinin is produced in oil sacs on  Artemisia annua  leaves Artemisinin... ...is produced by trichomes... ...found on  Artemisia annua  leaves...
Current process Artemisinin Plant synthesis Purification Artesunate Artelinate Arteether Artemether Chemical Conversions
Artemisinin-based drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Microbial synthesis of artemisinin Off-the-shelf components Knowledge Base Idea System Engineer a microorganism to produce artemisinin from an inexpensive, renewable resource.
Semi-synthesis of artemisinin ispH ispG idi isp A dxr dxs ispD DXP Pathway FPP Pyruvate + G3P Microbial synthesis ispF ispE Central metabolism Amorphadiene Artemisinic Acid ADS p450 Synthase Hydroxylase Unit CPR OPP Artemisinic Acid Purification OPP OPP Artemisinin Chemical Conversions Artesunate Artelinate Arteether Artemether
Constructing an artemisinic acid-producing microbe ispH ispG idi isp A dxr dxs ispD DXP Pathway FPP Pyruvate + G3P Microbial synthesis ispF ispE Central metabolism OPP Amorphadiene Artemisinic Acid ADS p450 Synthase Hydroxylase Unit CPR OPP OPP
Microbial synthesis of artemisinin Knowledge Base Idea System Off-the-shelf components
A chassis for artemisinin biosynthesis Knowledge Base Idea System Off-the-shelf components
Parts needed for artemisinin synthesis Knowledge Base Idea System Off-the-shelf components
How do we get the components we need?
How do we get the components we need? Genome sequencing Genome annotation Components
BioShack? “ Please send me your biological device as you described in your paper.” Reply:  “The device you requested is in this package … please use it as described in our paper.”
BioShack? “ It didn’t work as described in your paper.” Reply:  “In my hands, it worked as described in my paper … did you try X and Y and Z?”
Creating an amorphadiene-producing microbe ispH ispG idi isp A dxr dxs ispD DXP Pathway FPP Pyruvate + G3P Microbial synthesis Amorphadiene ADS Synthase ispF ispE Central metabolism ADS amorphadiene FPP OPP OPP OPP
Creating an amorphadiene-producing microbe ispH ispG idi isp A dxr dxs ispD DXP Pathway FPP Pyruvate + G3P Microbial synthesis Amorphadiene ADS Synthase ispF ispE Central metabolism EAS amorphadiene FPP “ Please send me your amorphadiene synthase as you described in your paper.” Reply:  “No … you are my competitor.” OPP OPP OPP
5- epi- aristolochene synthase  as a model ispH ispG idi isp A dxr dxs ispD DXP Pathway FPP Pyruvate + G3P Microbial synthesis ispF ispE Central metabolism 5-epi-aristolochene EAS Synthase Tobacco EAS 5- epi- aristolochene FPP OPP OPP OPP
Production of a model isoprenoid  in  E. coli Very low production of isoprenoid resulted when using the native gene 0.0001 0.001 0.01 0.1 1 10 100 1000 Construct Isoprenoid (mg/L)
Amorphadiene synthase by design ispH ispG idi isp A dxr dxs ispD DXP Pathway FPP Pyruvate + G3P Microbial synthesis Amorphadiene ADS Synthase ispF ispE Central metabolism ADS amorphadiene FPP OPP OPP OPP
Gene synthesis atcttgtgat catcccaaga caaaaccaga gaaaaagacc tgtctgtttt tttaagaagt  ctttatatta ttttttttgt cggagaatct tataagcatg gcttcaggag gatcaaagtc  ggcagctttc atgcttctga tgctgaatct tggtctctat ttcgtcatca ccatcatcgc  ttcttgggct gttaatcacg gcatcgagag aactcgcgag tctggtaact aacaaagata  acaactgatt aagtaacaat taatccaacg ttagaaaatg tcatcatcaa tcttcttttt  gtggtatttt gcagcgtcga cactgtcact tccggcgaag atattcccga tatacttccc  ggtggggaac atggcgaccg gttttttcgt aatattcacg ttaatcgccg gcgtcgtcgg  atcttgtgat catcccaaga caaaaccaga gaaaaagacc tgtctgtttt tttaagaagt  ctttatatta ttttttttgt cggagaatct tataagcatg gcttcaggag gatcaaagtc  ggcagctttc atgcttctga tgctgaatct tggtctctat ttcgtcatca ccatcatcgc  ttcttgggct gttaatcacg gcatcgagag aactcgcgag tctggtaact aacaaagata  acaactgatt aagtaacaat taatccaacg ttagaaaatg tcatcatcaa tcttcttttt  gtggtatttt gcagcgtcga cactgtcact tccggcgaag atattcccga tatacttccc  ggtggggaac atggcgaccg gttttttcgt aatattcacg ttaatcgccg gcgtcgtcgg  ,[object Object],[object Object],Plant Sequence Microbial Sequence
Gene synthesis improves amorphadiene production 142-fold improved production! 0.0001 0.001 0.01 0.1 1 10 100 1000 Construct Isoprenoid (mg/L)
Microbially-derived artemisinin ispH ispG idi isp A dxr dxs ispD Amorphadiene ADS DXP Pathway Synthase FPP Pyruvate + G3P ispF ispE Central metabolism Limitations in the native biosynthetic pathways OPP OPP OPP
A new pathway    … borrowed from nature ispH ispG idi isp A dxr dxs ispD FPP Pyruvate + G3P ispF ispE PMK MPD MK idi isp A HMGS atoB tHMGR Amorphadiene ADS FPP Mevalonate Acetyl- CoA The mevalonate pathway is responsible for cholesterol production. OPP
Metabolic pathway construction Acetyl-CoA P HMGS tHMGR atoB MevT Mevalonate FPP MBIS P PMK MPD MK idi Mevalonate ispA
Metabolic pathway construction lac I O P P RNAP atoB P HMGS tHMGR atoB
Metabolic pathway construction Connections between genes are not standardized P HMGS tHMGR atoB
BioBricks – Genetic Legos E =  Eco R1 Bg =  Bgl II Ba =  Bam H1 X =  Xho I Restriction site destroyed in the process B0034 AMP E Bg Ba X C0010 AMP E Bg Ba X Cut with E & Ba E Bg Ba B0034 Cut with E & Bg Mix & Ligate C0010 AMP Ba X B0034 E Bg C0010 AMP Ba X E Bg
Rapid assembly of metabolic pathways ispA idi MPD PMK MK ispA idi MPD PMK MK ispA idi MPD PMK MK ispA idi MPD PMK MK ispA idi MPD PMK MK Best producer Assemble using biobricks
The yeast mevalonate pathway improves yields ~90-fold 0.0001 0.001 0.01 0.1 1 10 100 1000 Construct Isoprenoid (mg/L)
Growth inhibition by MevT pathway Mevalonate tHMGR AtoB Acetyl-CoA Acetoacetyl -CoA HMG-CoA HMGS atoB HMGS tHMGR atoB HMGS tHMGR atoB HMGS tHMGR atoB HMGS tHMGR
Building a computer from off-the-shelf parts System Off-the-shelf components Knowledge Base Characterization Standard  Connections Independent Devices Models, Design, & Debugging Idea
Systems biology for debugging synthesis System Off-the-shelf components Idea ADS p450 Synthase Hydroxylase Unit CPR PMK MPD MK idi isp A HMGS atoB tHMGR Mevalonate pathway (TOP) Mevalonate pathway (BOTTOM) FPP Mevalonate Knowledge Base Debugging Metabolomics Proteomics Transcriptomics 0 5 10 15 20 25 Time [min] Asp Phe Glu Pro Ile Leu Lys Arg Val His Met
Accumulation of the toxic intermediate HMG-CoA Ac-CoA AcAc-CoA HMG-CoA Mev AtoB HmgS tHmgR PMK MPD MK idi isp A HMGS atoB tHMGR Amorphadiene ADS FPP Mevalonate Acetyl- CoA OPP
HMG-CoA inhibits fatty acid production PMK MPD MK idi isp A HMGS atoB tHMGR Amorphadiene ADS Mevalonate pathway (TOP) Mevalonate pathway (BOTTOM) Synthase FPP Mevalonate Acetyl- CoA HMG-CoA Fatty acid biosynthetic pathway OPP
HMG-CoA inhibits fatty acid production PMK MPD MK idi isp A HMGS atoB tHMGR Amorphadiene ADS Mevalonate pathway (TOP) Mevalonate pathway (BOTTOM) Synthase FPP Mevalonate Acetyl- CoA HMG-CoA Fatty acid biosynthetic pathway OPP
Addition of fatty acids to the growth medium restores growth PMK MPD MK idi isp A HMGS atoB tHMGR Amorphadiene ADS Mevalonate pathway (TOP) Mevalonate pathway (BOTTOM) Synthase FPP Mevalonate Acetyl- CoA HMG-CoA Fatty acid addition to the growth medium OPP HO O
Supplementation with saturated fatty acids improves growth Cell density (OD 600 ) Time post-induction (hrs) Active pathway No supplement Active pathway  16:0 Supplement Inactive pathway
Synthetic scaffolds: another way to solve the problem   Ac-CoA AcAc-CoA HMG-CoA Mev AtoB HmgS tHmgR tHmgR HmgS AtoB
Connecting metabolic pipes with synthetic scaffolds Connecting the enzymes in some way might reduce loss of intermediate to the bulk Ac-CoA AcAc-CoA HMG-CoA Mev AtoB HmgS tHmgR tHmgR HmgS AtoB
Connecting metabolic pipes with synthetic scaffolds Adding additional copies of rate-limiting enzymes might increase pathway flux Ac-CoA AcAc-CoA HMG-CoA Mev AtoB HmgS tHmgR tHmgR HmgS AtoB
There are no standards  for connecting enzymes together Ac-CoA AcAc-CoA HMG-CoA Mev AtoB HmgS tHmgR tHmgR HmgS AtoB
Synthetic scaffolds co-localize pathway enzymes and reduce intermediate runoff tHmgR HmgS AtoB AtoB HmgR HmgS
Synthetic scaffolds co-localize pathway enzymes and reduce intermediate runoff Scaffold P tet P BAD Dueber. 2009.  Nat. Biotech .   27:753. AtoB HmgS HmgR AtoB HmgR HmgS
Synthetic scaffolds can control relative enzyme ratios and optimize flux tHmgR HmgS AtoB Dueber. 2009.  Nat. Biotech .   27:753. AtoB HmgS HmgR HmgR HmgR
Variation in the number of  HmgS and HmgR on the scaffold Dueber. 2009.  Nat. Biotech .   27:753. AtoB HmgS HmgR HmgR HmgR HmgR AtoB HmgS HmgR HmgR AtoB HmgS HmgR AtoB HmgS HmgR HmgS AtoB HmgS HmgR HmgR HmgS AtoB HmgS HmgS HmgR HmgS HmgS HmgR HmgR HmgR AtoB HmgS HmgS HmgR HmgR HmgR HmgR AtoB HmgS HmgS HmgR HmgS HmgS HmgR AtoB HmgS HmgS HmgS HmgS HmgR HmgR HmgS
Synthetic scaffolds have a dramatic effect on the mevalonate pathway Dueber. 2009.  Nat. Biotech .   27:753. HmgS HmgR AtoB n = 1
Synthetic scaffolds can control relative enzyme ratios and optimize flux tHmgR tHmgR AtoB HmgS HmgR HmgR HmgS HmgS HmgS AtoB
Component optimization and debugging yields another 50 fold 0.0001 0.001 0.01 0.1 1 10 100 1000 Construct Isoprenoid (mg/L)
Fermentation optimization pushes yields beyond 25 g/L! Fermentation and further microbe optimization done by  Amyris . 0.0001 0.001 0.01 0.1 1 10 100 1000 Construct Isoprenoid (mg/L)
Identify final enzyme in pathway (P450/AMO) and transplant into  E. coli PMK MPD MK idi isp A HMGS atoB tHMGR Amorphadiene Artemisinic Acid ADS Mevalonate pathway (TOP) Mevalonate pathway (BOTTOM) p450 Synthase Hydroxyase Unit FPP Mevalonate CPR Acetyl- CoA A. annua p450 CPR Amorphadiene Artemisinic Acid OPP
Proposed artemisinin biosynthetic pathway Cytochrome P450  monooxygenase Alcohol  dehydrogenase Aldehyde  dehydrogenase FPP Amorphadiene Artemisinic acid Artemisinin C H 2 O H O H C H O O C C H 2 O H O H C H O O C
Lettuce, chicory, and sunflower produce isoprenoids like artemisinin Amorphadiene ( Artemisia annua )   Artemisinin H H O H O H H O O O H H O O Germacrene A (Chicory, sunflower and lettuce) O O O O H HO OH O O O H lettucenin A niveusin A O H O O P450’s involved
Alignment of known terpene hydroxylases
P450 candidate produces artemisinic acid FPP Amorphadiene Artemisinic acid C H 2 O H O H C H O O C 121 248 93 188 79 105 216 136 162 173 145 55 67 201 233 121 93 248 79 188 105 136 216 162 173 145 55 67 201 233 Relative Ion Abundance Peak 1 Yeast product Peak 2 Artemisinic acid m/z
Completing the biosynthetic pathway in  E. coli p450 Amorphadiene Artemisinic Acid 1 2 3 >25 g/L Current titer in E. coli (lab scale) > 1 g/L P450/AMO Catalyzes 3 Separate Oxidations
Research, Development &  Delivery Keasling  Laboratory Amyris  Biotechnologies Sanofi-Aventis
Production of advanced biofuels System Off-the-shelf components Idea Knowledge Base
Production of advanced biofuels Off-the-shelf components Idea Knowledge Base System
Biofuels beyond ethanol ,[object Object],[object Object],[object Object],[object Object]
Microbial synthesis of biofuels ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Production of advanced biofuels Off-the-shelf components Idea Knowledge Base System
Production of advanced biofuels Idea Knowledge Base System Off-the-shelf components lmnS gerS pptS waxS fnsS
Acknowledgements Funding Department of Energy National Science Foundation Office of Naval Research University of California Discovery Grant Bill & Melinda Gates Foundation Keasling lab Jennifer Anthony Michelle Chang Howard Chou John Dueber Connie Kang Lance Kizer Jim Kirby Taek Soon Lee Vincent Martin Karyn Newman Farnaz Nowroozi Mario Ouellet Eric Paradise Chris Petzold Brian Pfleger Doug Pitera Dae-Kyun Ro Christina Smolke Sydnor Withers Gabriel Wu Yasuo Yoshikuni Amyris # Jack Newman Chris Paddon Kinkead Reiling Rika Regentin Neil Renninger # Jay Keasling has a financial interest in Amyris & LS9.  Joint Genome Institute

More Related Content

Similar to 09 CeoMeeting- Final Talk_Jay Keasling

Partial thesis defence presentation
Partial thesis defence presentationPartial thesis defence presentation
Partial thesis defence presentationSanjeewaRupasinghe
 
Metabolic engineering of Saccharomyces cerevisiae for isoprenoids production ...
Metabolic engineering of Saccharomyces cerevisiae for isoprenoids production ...Metabolic engineering of Saccharomyces cerevisiae for isoprenoids production ...
Metabolic engineering of Saccharomyces cerevisiae for isoprenoids production ...
rutayisirer
 
Downstream Processing in Biopharmaceuticals
Downstream Processing in BiopharmaceuticalsDownstream Processing in Biopharmaceuticals
Downstream Processing in Biopharmaceuticals
angelsalaman
 
Polymerase Chain Reaction (PCR).pdf
Polymerase Chain Reaction (PCR).pdfPolymerase Chain Reaction (PCR).pdf
Polymerase Chain Reaction (PCR).pdf
Ayat Samy
 
Auxin proteo controller
Auxin proteo controllerAuxin proteo controller
Auxin proteo controllerYumi Saiki
 
Custom peptide synthesis services
Custom peptide synthesis servicesCustom peptide synthesis services
Custom peptide synthesis services
Life Tein
 
2015.04.08-Next-generation-sequencing-issues
2015.04.08-Next-generation-sequencing-issues2015.04.08-Next-generation-sequencing-issues
2015.04.08-Next-generation-sequencing-issuesDongyan Zhao
 
Recombinant protein expression and purification Lecture
Recombinant protein expression and purification LectureRecombinant protein expression and purification Lecture
Recombinant protein expression and purification Lecture
test
 
L50149_NGS_Illumina_TruSeq-NS
L50149_NGS_Illumina_TruSeq-NSL50149_NGS_Illumina_TruSeq-NS
L50149_NGS_Illumina_TruSeq-NSLance Larka
 
Ijetcas14 510
Ijetcas14 510Ijetcas14 510
Ijetcas14 510
Iasir Journals
 
Proteins – Basics you need to know for Proteomics
Proteins – Basics you need to know for ProteomicsProteins – Basics you need to know for Proteomics
Proteins – Basics you need to know for Proteomics
Lionel Wolberger
 
Basic Polymerase Chain Reaction for Bachelor Degree
Basic Polymerase Chain Reaction for Bachelor DegreeBasic Polymerase Chain Reaction for Bachelor Degree
Basic Polymerase Chain Reaction for Bachelor Degree
leonardotejogunawan
 
sem4-cdna sythesis,pcr,designing primers for pcr, synthesis of genes, shotgun...
sem4-cdna sythesis,pcr,designing primers for pcr, synthesis of genes, shotgun...sem4-cdna sythesis,pcr,designing primers for pcr, synthesis of genes, shotgun...
sem4-cdna sythesis,pcr,designing primers for pcr, synthesis of genes, shotgun...JYOTI DEVENDRA
 
Angiotensin Rennin Polypharmacology Analysis
Angiotensin Rennin Polypharmacology AnalysisAngiotensin Rennin Polypharmacology Analysis
Angiotensin Rennin Polypharmacology Analysis
Larry Norder
 
63 bacterialgenecontrol2007
63 bacterialgenecontrol200763 bacterialgenecontrol2007
63 bacterialgenecontrol2007sbarkanic
 
Advantages And Disadvantages Of Reverse Sequence Syphilis...
Advantages And Disadvantages Of Reverse Sequence Syphilis...Advantages And Disadvantages Of Reverse Sequence Syphilis...
Advantages And Disadvantages Of Reverse Sequence Syphilis...
Lynn Holkesvik
 

Similar to 09 CeoMeeting- Final Talk_Jay Keasling (20)

Partial thesis defence presentation
Partial thesis defence presentationPartial thesis defence presentation
Partial thesis defence presentation
 
Metabolic engineering of Saccharomyces cerevisiae for isoprenoids production ...
Metabolic engineering of Saccharomyces cerevisiae for isoprenoids production ...Metabolic engineering of Saccharomyces cerevisiae for isoprenoids production ...
Metabolic engineering of Saccharomyces cerevisiae for isoprenoids production ...
 
Downstream Processing in Biopharmaceuticals
Downstream Processing in BiopharmaceuticalsDownstream Processing in Biopharmaceuticals
Downstream Processing in Biopharmaceuticals
 
Polymerase Chain Reaction (PCR).pdf
Polymerase Chain Reaction (PCR).pdfPolymerase Chain Reaction (PCR).pdf
Polymerase Chain Reaction (PCR).pdf
 
Auxin proteo controller
Auxin proteo controllerAuxin proteo controller
Auxin proteo controller
 
Custom peptide synthesis services
Custom peptide synthesis servicesCustom peptide synthesis services
Custom peptide synthesis services
 
2015.04.08-Next-generation-sequencing-issues
2015.04.08-Next-generation-sequencing-issues2015.04.08-Next-generation-sequencing-issues
2015.04.08-Next-generation-sequencing-issues
 
Recombinant protein expression and purification Lecture
Recombinant protein expression and purification LectureRecombinant protein expression and purification Lecture
Recombinant protein expression and purification Lecture
 
L50149_NGS_Illumina_TruSeq-NS
L50149_NGS_Illumina_TruSeq-NSL50149_NGS_Illumina_TruSeq-NS
L50149_NGS_Illumina_TruSeq-NS
 
Ijetcas14 510
Ijetcas14 510Ijetcas14 510
Ijetcas14 510
 
Proteins – Basics you need to know for Proteomics
Proteins – Basics you need to know for ProteomicsProteins – Basics you need to know for Proteomics
Proteins – Basics you need to know for Proteomics
 
Group b
Group bGroup b
Group b
 
Basic Polymerase Chain Reaction for Bachelor Degree
Basic Polymerase Chain Reaction for Bachelor DegreeBasic Polymerase Chain Reaction for Bachelor Degree
Basic Polymerase Chain Reaction for Bachelor Degree
 
sem4-cdna sythesis,pcr,designing primers for pcr, synthesis of genes, shotgun...
sem4-cdna sythesis,pcr,designing primers for pcr, synthesis of genes, shotgun...sem4-cdna sythesis,pcr,designing primers for pcr, synthesis of genes, shotgun...
sem4-cdna sythesis,pcr,designing primers for pcr, synthesis of genes, shotgun...
 
Mb cardiovascular
Mb cardiovascularMb cardiovascular
Mb cardiovascular
 
Angiotensin Rennin Polypharmacology Analysis
Angiotensin Rennin Polypharmacology AnalysisAngiotensin Rennin Polypharmacology Analysis
Angiotensin Rennin Polypharmacology Analysis
 
Breast final
Breast finalBreast final
Breast final
 
63 bacterialgenecontrol2007
63 bacterialgenecontrol200763 bacterialgenecontrol2007
63 bacterialgenecontrol2007
 
Highlight catalogue
Highlight catalogueHighlight catalogue
Highlight catalogue
 
Advantages And Disadvantages Of Reverse Sequence Syphilis...
Advantages And Disadvantages Of Reverse Sequence Syphilis...Advantages And Disadvantages Of Reverse Sequence Syphilis...
Advantages And Disadvantages Of Reverse Sequence Syphilis...
 

More from MLSCF

09 CeoMeeting- Session 5- Biotech Corp
09 CeoMeeting- Session 5- Biotech Corp09 CeoMeeting- Session 5- Biotech Corp
09 CeoMeeting- Session 5- Biotech Corp
MLSCF
 
09 CeoMeeting- Session 5- Abunda
09 CeoMeeting- Session 5- Abunda09 CeoMeeting- Session 5- Abunda
09 CeoMeeting- Session 5- Abunda
MLSCF
 
09 CeoMeeting- Session 4- Medicines for Malaria
09 CeoMeeting- Session 4- Medicines for Malaria09 CeoMeeting- Session 4- Medicines for Malaria
09 CeoMeeting- Session 4- Medicines for Malaria
MLSCF
 
09 CeoMeeting- Session 4- Sentinext
09 CeoMeeting- Session 4- Sentinext09 CeoMeeting- Session 4- Sentinext
09 CeoMeeting- Session 4- Sentinext
MLSCF
 
09 CeoMeeting- Session 4- Artisan
09 CeoMeeting- Session 4- Artisan09 CeoMeeting- Session 4- Artisan
09 CeoMeeting- Session 4- Artisan
MLSCF
 
09 CeoMeeting- Session 4- Chakra
09 CeoMeeting- Session 4- Chakra09 CeoMeeting- Session 4- Chakra
09 CeoMeeting- Session 4- Chakra
MLSCF
 
09 CeoMeeting- Session 3- Dr. Kishore
09 CeoMeeting- Session 3- Dr. Kishore09 CeoMeeting- Session 3- Dr. Kishore
09 CeoMeeting- Session 3- Dr. Kishore
MLSCF
 
09 CeoMeeting- Session 3- Sime Darby
09 CeoMeeting- Session 3- Sime Darby09 CeoMeeting- Session 3- Sime Darby
09 CeoMeeting- Session 3- Sime Darby
MLSCF
 
09 CeoMeeting- Session 3- Chromatin
09 CeoMeeting- Session 3- Chromatin09 CeoMeeting- Session 3- Chromatin
09 CeoMeeting- Session 3- Chromatin
MLSCF
 
09 CeoMeeting- Session 3- Metahelix
09 CeoMeeting- Session 3- Metahelix09 CeoMeeting- Session 3- Metahelix
09 CeoMeeting- Session 3- Metahelix
MLSCF
 
09 CeoMeeting- Session1- Cobalt
09 CeoMeeting- Session1- Cobalt09 CeoMeeting- Session1- Cobalt
09 CeoMeeting- Session1- CobaltMLSCF
 
09 CeoMeeting- Session1- Segetis
09 CeoMeeting- Session1- Segetis09 CeoMeeting- Session1- Segetis
09 CeoMeeting- Session1- SegetisMLSCF
 
09 CeoMeeting- Session1- Gevo
09 CeoMeeting- Session1- Gevo09 CeoMeeting- Session1- Gevo
09 CeoMeeting- Session1- Gevo
MLSCF
 
09 CeoMeeting- Session 2- Hovid
09 CeoMeeting- Session 2- Hovid09 CeoMeeting- Session 2- Hovid
09 CeoMeeting- Session 2- Hovid
MLSCF
 
09 CeoMeeting- Session2- Battelle
09 CeoMeeting- Session2- Battelle09 CeoMeeting- Session2- Battelle
09 CeoMeeting- Session2- Battelle
MLSCF
 
09 CeoMeeting- Session2- Mascoma
09 CeoMeeting- Session2- Mascoma09 CeoMeeting- Session2- Mascoma
09 CeoMeeting- Session2- Mascoma
MLSCF
 
09 CeoMeeting- Keynote
09 CeoMeeting- Keynote09 CeoMeeting- Keynote
09 CeoMeeting- KeynoteMLSCF
 

More from MLSCF (17)

09 CeoMeeting- Session 5- Biotech Corp
09 CeoMeeting- Session 5- Biotech Corp09 CeoMeeting- Session 5- Biotech Corp
09 CeoMeeting- Session 5- Biotech Corp
 
09 CeoMeeting- Session 5- Abunda
09 CeoMeeting- Session 5- Abunda09 CeoMeeting- Session 5- Abunda
09 CeoMeeting- Session 5- Abunda
 
09 CeoMeeting- Session 4- Medicines for Malaria
09 CeoMeeting- Session 4- Medicines for Malaria09 CeoMeeting- Session 4- Medicines for Malaria
09 CeoMeeting- Session 4- Medicines for Malaria
 
09 CeoMeeting- Session 4- Sentinext
09 CeoMeeting- Session 4- Sentinext09 CeoMeeting- Session 4- Sentinext
09 CeoMeeting- Session 4- Sentinext
 
09 CeoMeeting- Session 4- Artisan
09 CeoMeeting- Session 4- Artisan09 CeoMeeting- Session 4- Artisan
09 CeoMeeting- Session 4- Artisan
 
09 CeoMeeting- Session 4- Chakra
09 CeoMeeting- Session 4- Chakra09 CeoMeeting- Session 4- Chakra
09 CeoMeeting- Session 4- Chakra
 
09 CeoMeeting- Session 3- Dr. Kishore
09 CeoMeeting- Session 3- Dr. Kishore09 CeoMeeting- Session 3- Dr. Kishore
09 CeoMeeting- Session 3- Dr. Kishore
 
09 CeoMeeting- Session 3- Sime Darby
09 CeoMeeting- Session 3- Sime Darby09 CeoMeeting- Session 3- Sime Darby
09 CeoMeeting- Session 3- Sime Darby
 
09 CeoMeeting- Session 3- Chromatin
09 CeoMeeting- Session 3- Chromatin09 CeoMeeting- Session 3- Chromatin
09 CeoMeeting- Session 3- Chromatin
 
09 CeoMeeting- Session 3- Metahelix
09 CeoMeeting- Session 3- Metahelix09 CeoMeeting- Session 3- Metahelix
09 CeoMeeting- Session 3- Metahelix
 
09 CeoMeeting- Session1- Cobalt
09 CeoMeeting- Session1- Cobalt09 CeoMeeting- Session1- Cobalt
09 CeoMeeting- Session1- Cobalt
 
09 CeoMeeting- Session1- Segetis
09 CeoMeeting- Session1- Segetis09 CeoMeeting- Session1- Segetis
09 CeoMeeting- Session1- Segetis
 
09 CeoMeeting- Session1- Gevo
09 CeoMeeting- Session1- Gevo09 CeoMeeting- Session1- Gevo
09 CeoMeeting- Session1- Gevo
 
09 CeoMeeting- Session 2- Hovid
09 CeoMeeting- Session 2- Hovid09 CeoMeeting- Session 2- Hovid
09 CeoMeeting- Session 2- Hovid
 
09 CeoMeeting- Session2- Battelle
09 CeoMeeting- Session2- Battelle09 CeoMeeting- Session2- Battelle
09 CeoMeeting- Session2- Battelle
 
09 CeoMeeting- Session2- Mascoma
09 CeoMeeting- Session2- Mascoma09 CeoMeeting- Session2- Mascoma
09 CeoMeeting- Session2- Mascoma
 
09 CeoMeeting- Keynote
09 CeoMeeting- Keynote09 CeoMeeting- Keynote
09 CeoMeeting- Keynote
 

Recently uploaded

Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdfSmart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
91mobiles
 
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdfFIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
Sri Ambati
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
Product School
 
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Tobias Schneck
 
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMsTo Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
Paul Groth
 
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Jeffrey Haguewood
 
Essentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with ParametersEssentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with Parameters
Safe Software
 
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered QualitySoftware Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Inflectra
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
ThousandEyes
 
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
Product School
 
Key Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdfKey Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdf
Cheryl Hung
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
Laura Byrne
 
UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3
DianaGray10
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
BookNet Canada
 
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
Product School
 
Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
Thijs Feryn
 
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptxIOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
Abida Shariff
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
James Anderson
 
Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*
Frank van Harmelen
 

Recently uploaded (20)

Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdfSmart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
 
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdfFIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
 
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
 
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMsTo Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
 
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
 
Essentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with ParametersEssentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with Parameters
 
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered QualitySoftware Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
 
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
 
Key Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdfKey Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdf
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
 
UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
 
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
 
Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
 
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptxIOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
 
Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*
 

09 CeoMeeting- Final Talk_Jay Keasling

  • 1. Synthetic Biology: From Bugs to Drugs and Fuels Jay D. Keasling Joint BioEnergy Institute Lawrence Berkeley National Laboratory University of California, Berkeley
  • 2. Building a computer from off-the-shelf parts System Off-the-shelf components Idea Knowledge Base
  • 3. Building a computer from off-the-shelf parts System Off-the-shelf components Idea Knowledge Base
  • 4. Building a computer from off-the-shelf parts System Off-the-shelf components Idea Knowledge Base
  • 5. Building a computer from off-the-shelf parts System Off-the-shelf components Idea Knowledge Base
  • 6. Building a computer from off-the-shelf parts System Off-the-shelf components Idea Knowledge Base
  • 7. Building a computer from off-the-shelf parts System Off-the-shelf components Knowledge Base Characterization Idea
  • 8. Building a computer from off-the-shelf parts System Off-the-shelf components Knowledge Base Characterization Standard Connections Idea
  • 9. Building a computer from off-the-shelf parts System Off-the-shelf components Knowledge Base Characterization Standard Connections Independent Devices Idea
  • 10. Building a computer from off-the-shelf parts System Off-the-shelf components Knowledge Base Characterization Standard Connections Independent Devices Models, Design, & Debugging Idea
  • 11. Building a computer from off-the-shelf parts System Off-the-shelf components Knowledge Base Characterization Standard Connections Independent Devices Models, Design, & Debugging Silicon Wafer Processing Idea
  • 13. Synthesis of Styrene System Off-the-shelf components Idea Knowledge Base
  • 14. Synthesis of Styrene System Off-the-shelf components Idea Knowledge Base
  • 15. Synthesis of Styrene System Off-the-shelf components Idea Knowledge Base
  • 16. Synthesis of Styrene System Off-the-shelf components Idea Knowledge Base Chemistry
  • 17. Synthesis of Styrene System Off-the-shelf components Idea Knowledge Base Chemistry Kinetics & Reactor Design
  • 18. Synthesis of Styrene System Off-the-shelf components Knowledge Base Chemistry Kinetics & Reactor Design Mass Transfer Process Design Standard Connections Idea
  • 19.
  • 20. Microbial synthesis of artemisinin System Off-the-shelf components Knowledge Base Idea
  • 21.
  • 22.
  • 24. A brief history of artemisinin 168 B.C. Recipes For 52 Kinds Of Diseases found in the Mawangdui Han Dynasty tomb  Hemorrhoids 340 A.D. Zhou Hou Bei Ji Fang (Handbook of Prescriptions for Emergency Treatments)  Fevers (malaria) 1972 Active ingredient (artemisinin) isolated
  • 25. Artemisinin is produced in oil sacs on Artemisia annua leaves Artemisinin... ...is produced by trichomes... ...found on Artemisia annua leaves...
  • 26. Current process Artemisinin Plant synthesis Purification Artesunate Artelinate Arteether Artemether Chemical Conversions
  • 27.
  • 28. Microbial synthesis of artemisinin Off-the-shelf components Knowledge Base Idea System Engineer a microorganism to produce artemisinin from an inexpensive, renewable resource.
  • 29. Semi-synthesis of artemisinin ispH ispG idi isp A dxr dxs ispD DXP Pathway FPP Pyruvate + G3P Microbial synthesis ispF ispE Central metabolism Amorphadiene Artemisinic Acid ADS p450 Synthase Hydroxylase Unit CPR OPP Artemisinic Acid Purification OPP OPP Artemisinin Chemical Conversions Artesunate Artelinate Arteether Artemether
  • 30. Constructing an artemisinic acid-producing microbe ispH ispG idi isp A dxr dxs ispD DXP Pathway FPP Pyruvate + G3P Microbial synthesis ispF ispE Central metabolism OPP Amorphadiene Artemisinic Acid ADS p450 Synthase Hydroxylase Unit CPR OPP OPP
  • 31. Microbial synthesis of artemisinin Knowledge Base Idea System Off-the-shelf components
  • 32. A chassis for artemisinin biosynthesis Knowledge Base Idea System Off-the-shelf components
  • 33. Parts needed for artemisinin synthesis Knowledge Base Idea System Off-the-shelf components
  • 34. How do we get the components we need?
  • 35. How do we get the components we need? Genome sequencing Genome annotation Components
  • 36. BioShack? “ Please send me your biological device as you described in your paper.” Reply: “The device you requested is in this package … please use it as described in our paper.”
  • 37. BioShack? “ It didn’t work as described in your paper.” Reply: “In my hands, it worked as described in my paper … did you try X and Y and Z?”
  • 38. Creating an amorphadiene-producing microbe ispH ispG idi isp A dxr dxs ispD DXP Pathway FPP Pyruvate + G3P Microbial synthesis Amorphadiene ADS Synthase ispF ispE Central metabolism ADS amorphadiene FPP OPP OPP OPP
  • 39. Creating an amorphadiene-producing microbe ispH ispG idi isp A dxr dxs ispD DXP Pathway FPP Pyruvate + G3P Microbial synthesis Amorphadiene ADS Synthase ispF ispE Central metabolism EAS amorphadiene FPP “ Please send me your amorphadiene synthase as you described in your paper.” Reply: “No … you are my competitor.” OPP OPP OPP
  • 40. 5- epi- aristolochene synthase as a model ispH ispG idi isp A dxr dxs ispD DXP Pathway FPP Pyruvate + G3P Microbial synthesis ispF ispE Central metabolism 5-epi-aristolochene EAS Synthase Tobacco EAS 5- epi- aristolochene FPP OPP OPP OPP
  • 41. Production of a model isoprenoid in E. coli Very low production of isoprenoid resulted when using the native gene 0.0001 0.001 0.01 0.1 1 10 100 1000 Construct Isoprenoid (mg/L)
  • 42. Amorphadiene synthase by design ispH ispG idi isp A dxr dxs ispD DXP Pathway FPP Pyruvate + G3P Microbial synthesis Amorphadiene ADS Synthase ispF ispE Central metabolism ADS amorphadiene FPP OPP OPP OPP
  • 43.
  • 44. Gene synthesis improves amorphadiene production 142-fold improved production! 0.0001 0.001 0.01 0.1 1 10 100 1000 Construct Isoprenoid (mg/L)
  • 45. Microbially-derived artemisinin ispH ispG idi isp A dxr dxs ispD Amorphadiene ADS DXP Pathway Synthase FPP Pyruvate + G3P ispF ispE Central metabolism Limitations in the native biosynthetic pathways OPP OPP OPP
  • 46. A new pathway … borrowed from nature ispH ispG idi isp A dxr dxs ispD FPP Pyruvate + G3P ispF ispE PMK MPD MK idi isp A HMGS atoB tHMGR Amorphadiene ADS FPP Mevalonate Acetyl- CoA The mevalonate pathway is responsible for cholesterol production. OPP
  • 47. Metabolic pathway construction Acetyl-CoA P HMGS tHMGR atoB MevT Mevalonate FPP MBIS P PMK MPD MK idi Mevalonate ispA
  • 48. Metabolic pathway construction lac I O P P RNAP atoB P HMGS tHMGR atoB
  • 49. Metabolic pathway construction Connections between genes are not standardized P HMGS tHMGR atoB
  • 50. BioBricks – Genetic Legos E = Eco R1 Bg = Bgl II Ba = Bam H1 X = Xho I Restriction site destroyed in the process B0034 AMP E Bg Ba X C0010 AMP E Bg Ba X Cut with E & Ba E Bg Ba B0034 Cut with E & Bg Mix & Ligate C0010 AMP Ba X B0034 E Bg C0010 AMP Ba X E Bg
  • 51. Rapid assembly of metabolic pathways ispA idi MPD PMK MK ispA idi MPD PMK MK ispA idi MPD PMK MK ispA idi MPD PMK MK ispA idi MPD PMK MK Best producer Assemble using biobricks
  • 52. The yeast mevalonate pathway improves yields ~90-fold 0.0001 0.001 0.01 0.1 1 10 100 1000 Construct Isoprenoid (mg/L)
  • 53. Growth inhibition by MevT pathway Mevalonate tHMGR AtoB Acetyl-CoA Acetoacetyl -CoA HMG-CoA HMGS atoB HMGS tHMGR atoB HMGS tHMGR atoB HMGS tHMGR atoB HMGS tHMGR
  • 54. Building a computer from off-the-shelf parts System Off-the-shelf components Knowledge Base Characterization Standard Connections Independent Devices Models, Design, & Debugging Idea
  • 55. Systems biology for debugging synthesis System Off-the-shelf components Idea ADS p450 Synthase Hydroxylase Unit CPR PMK MPD MK idi isp A HMGS atoB tHMGR Mevalonate pathway (TOP) Mevalonate pathway (BOTTOM) FPP Mevalonate Knowledge Base Debugging Metabolomics Proteomics Transcriptomics 0 5 10 15 20 25 Time [min] Asp Phe Glu Pro Ile Leu Lys Arg Val His Met
  • 56. Accumulation of the toxic intermediate HMG-CoA Ac-CoA AcAc-CoA HMG-CoA Mev AtoB HmgS tHmgR PMK MPD MK idi isp A HMGS atoB tHMGR Amorphadiene ADS FPP Mevalonate Acetyl- CoA OPP
  • 57. HMG-CoA inhibits fatty acid production PMK MPD MK idi isp A HMGS atoB tHMGR Amorphadiene ADS Mevalonate pathway (TOP) Mevalonate pathway (BOTTOM) Synthase FPP Mevalonate Acetyl- CoA HMG-CoA Fatty acid biosynthetic pathway OPP
  • 58. HMG-CoA inhibits fatty acid production PMK MPD MK idi isp A HMGS atoB tHMGR Amorphadiene ADS Mevalonate pathway (TOP) Mevalonate pathway (BOTTOM) Synthase FPP Mevalonate Acetyl- CoA HMG-CoA Fatty acid biosynthetic pathway OPP
  • 59. Addition of fatty acids to the growth medium restores growth PMK MPD MK idi isp A HMGS atoB tHMGR Amorphadiene ADS Mevalonate pathway (TOP) Mevalonate pathway (BOTTOM) Synthase FPP Mevalonate Acetyl- CoA HMG-CoA Fatty acid addition to the growth medium OPP HO O
  • 60. Supplementation with saturated fatty acids improves growth Cell density (OD 600 ) Time post-induction (hrs) Active pathway No supplement Active pathway 16:0 Supplement Inactive pathway
  • 61. Synthetic scaffolds: another way to solve the problem Ac-CoA AcAc-CoA HMG-CoA Mev AtoB HmgS tHmgR tHmgR HmgS AtoB
  • 62. Connecting metabolic pipes with synthetic scaffolds Connecting the enzymes in some way might reduce loss of intermediate to the bulk Ac-CoA AcAc-CoA HMG-CoA Mev AtoB HmgS tHmgR tHmgR HmgS AtoB
  • 63. Connecting metabolic pipes with synthetic scaffolds Adding additional copies of rate-limiting enzymes might increase pathway flux Ac-CoA AcAc-CoA HMG-CoA Mev AtoB HmgS tHmgR tHmgR HmgS AtoB
  • 64. There are no standards for connecting enzymes together Ac-CoA AcAc-CoA HMG-CoA Mev AtoB HmgS tHmgR tHmgR HmgS AtoB
  • 65. Synthetic scaffolds co-localize pathway enzymes and reduce intermediate runoff tHmgR HmgS AtoB AtoB HmgR HmgS
  • 66. Synthetic scaffolds co-localize pathway enzymes and reduce intermediate runoff Scaffold P tet P BAD Dueber. 2009. Nat. Biotech . 27:753. AtoB HmgS HmgR AtoB HmgR HmgS
  • 67. Synthetic scaffolds can control relative enzyme ratios and optimize flux tHmgR HmgS AtoB Dueber. 2009. Nat. Biotech . 27:753. AtoB HmgS HmgR HmgR HmgR
  • 68. Variation in the number of HmgS and HmgR on the scaffold Dueber. 2009. Nat. Biotech . 27:753. AtoB HmgS HmgR HmgR HmgR HmgR AtoB HmgS HmgR HmgR AtoB HmgS HmgR AtoB HmgS HmgR HmgS AtoB HmgS HmgR HmgR HmgS AtoB HmgS HmgS HmgR HmgS HmgS HmgR HmgR HmgR AtoB HmgS HmgS HmgR HmgR HmgR HmgR AtoB HmgS HmgS HmgR HmgS HmgS HmgR AtoB HmgS HmgS HmgS HmgS HmgR HmgR HmgS
  • 69. Synthetic scaffolds have a dramatic effect on the mevalonate pathway Dueber. 2009. Nat. Biotech . 27:753. HmgS HmgR AtoB n = 1
  • 70. Synthetic scaffolds can control relative enzyme ratios and optimize flux tHmgR tHmgR AtoB HmgS HmgR HmgR HmgS HmgS HmgS AtoB
  • 71. Component optimization and debugging yields another 50 fold 0.0001 0.001 0.01 0.1 1 10 100 1000 Construct Isoprenoid (mg/L)
  • 72. Fermentation optimization pushes yields beyond 25 g/L! Fermentation and further microbe optimization done by Amyris . 0.0001 0.001 0.01 0.1 1 10 100 1000 Construct Isoprenoid (mg/L)
  • 73. Identify final enzyme in pathway (P450/AMO) and transplant into E. coli PMK MPD MK idi isp A HMGS atoB tHMGR Amorphadiene Artemisinic Acid ADS Mevalonate pathway (TOP) Mevalonate pathway (BOTTOM) p450 Synthase Hydroxyase Unit FPP Mevalonate CPR Acetyl- CoA A. annua p450 CPR Amorphadiene Artemisinic Acid OPP
  • 74. Proposed artemisinin biosynthetic pathway Cytochrome P450 monooxygenase Alcohol dehydrogenase Aldehyde dehydrogenase FPP Amorphadiene Artemisinic acid Artemisinin C H 2 O H O H C H O O C C H 2 O H O H C H O O C
  • 75. Lettuce, chicory, and sunflower produce isoprenoids like artemisinin Amorphadiene ( Artemisia annua ) Artemisinin H H O H O H H O O O H H O O Germacrene A (Chicory, sunflower and lettuce) O O O O H HO OH O O O H lettucenin A niveusin A O H O O P450’s involved
  • 76. Alignment of known terpene hydroxylases
  • 77. P450 candidate produces artemisinic acid FPP Amorphadiene Artemisinic acid C H 2 O H O H C H O O C 121 248 93 188 79 105 216 136 162 173 145 55 67 201 233 121 93 248 79 188 105 136 216 162 173 145 55 67 201 233 Relative Ion Abundance Peak 1 Yeast product Peak 2 Artemisinic acid m/z
  • 78. Completing the biosynthetic pathway in E. coli p450 Amorphadiene Artemisinic Acid 1 2 3 >25 g/L Current titer in E. coli (lab scale) > 1 g/L P450/AMO Catalyzes 3 Separate Oxidations
  • 79. Research, Development & Delivery Keasling Laboratory Amyris Biotechnologies Sanofi-Aventis
  • 80. Production of advanced biofuels System Off-the-shelf components Idea Knowledge Base
  • 81. Production of advanced biofuels Off-the-shelf components Idea Knowledge Base System
  • 82.
  • 83.
  • 84. Production of advanced biofuels Off-the-shelf components Idea Knowledge Base System
  • 85. Production of advanced biofuels Idea Knowledge Base System Off-the-shelf components lmnS gerS pptS waxS fnsS
  • 86. Acknowledgements Funding Department of Energy National Science Foundation Office of Naval Research University of California Discovery Grant Bill & Melinda Gates Foundation Keasling lab Jennifer Anthony Michelle Chang Howard Chou John Dueber Connie Kang Lance Kizer Jim Kirby Taek Soon Lee Vincent Martin Karyn Newman Farnaz Nowroozi Mario Ouellet Eric Paradise Chris Petzold Brian Pfleger Doug Pitera Dae-Kyun Ro Christina Smolke Sydnor Withers Gabriel Wu Yasuo Yoshikuni Amyris # Jack Newman Chris Paddon Kinkead Reiling Rika Regentin Neil Renninger # Jay Keasling has a financial interest in Amyris & LS9. Joint Genome Institute

Editor's Notes

  1. Ancient Chinese medical texts dating from around 150 B.C. suggest the use of sweet Annie for people with hemorrhoids .[1] Other writings from 340 A.D. are the first known to mention sweet Annie as a treatment for people with fevers.[2] It has been used ever since for a variety of infections in Traditional Chinese Medicine . 1. Foster S, Yue CX. Herbal Emissaries: Bringing Chinese Herbs to the West. Rochester, VT: Healing Arts Press, 1992, 322. 2. Foster S, Yue CX. Herbal Emissaries: Bringing Chinese Herbs to the West. Rochester, VT: Healing Arts Press, 1992, 322.
  2. One way you can improve expression of plant genes (and in fact genes from many different organisms) in a microbial host is to resynthesize the gene, making it look like a microbial gene even though it encodes the plant enzyme. The way we do this is to run the amino acid sequence through a computer program that exchanges all of the rare codons in the gene (at least the codons that are rare for the host (E. coli)) for codons that are used frequently by E. coli.
  3. This new gene improved production of amorphadiene 142 fold (not shown to scale in the graph). In essence, we eliminated a bottleneck and opened up the metabolic pipes at the end of the process.
  4. So, we decided that the best approach was to bring an entirely new metabolic pathway into the cell. The new pathway that we added is the mevalonate pathway from yeast that is responsible for cholesterol biosynthesis. Since no other growth factors for cell growth were produced by this pathway, we would not have to worry about it disrupting growth. The pathway functioned beautifully and improved production another 90 fold.
  5. So, we decided that the best approach was to bring an entirely new metabolic pathway into the cell. The new pathway that we added is the mevalonate pathway from yeast that is responsible for cholesterol biosynthesis. Since no other growth factors for cell growth were produced by this pathway, we would not have to worry about it disrupting growth. The pathway functioned beautifully and improved production another 90 fold.
  6. This is what is known of the artemisinin biosynthetic pathway. It begins with farnesyl diphosphate, a 15-carbon precursor that is found in every organism. Besides being the precursor to artemisinin, farnesyl diphosphate is also the precursor to cholesterol.
  7. The goals of the Fuels Synthesis Division are to develop organisms that can efficiently produce, in high concentration, existing and next generation biofuels from the sugars of cellulose depolymerization and organisms that can withstand high concentrations of the fuels. Early deliverables from the Fuels Synthesis Division will be pathways for production of next generation biofuels enabled by our strength in synthetic biology. Understanding the toxicity and stress encountered by organisms in response to fuels, enabled by functional genomics methods developed through the Genomics:GTL programs and informatics to integrate these methods, will allow us to engineer organisms that are better able to withstand high concentrations of the fuels. Using mathematical models of metabolism and gene regulation we will engineer microorganisms to efficient convert sugars into biofuels. Our long-term goal is to develop microorganisms capable of depolymerizing cellulose into sugars and converting the sugars into biofuels in a single pot.